Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer

ArticleAçık Erişim

Özet

Breast cancer is a heterogeneous disease and may present with different clinical and biological characteristics. At present, breast cancer is divided into molecular subgroups besides its histopathological classification. Decision for adjuvant chemotherapy is made based on not only histopathological characteristics but also molecular and genomic characteristics using indices, guidelines and calculators in early-stage breast cancer. Making a treatment plan through all these prognostic and predictive methods according to risk categories aims at preventing unnecessary or useless treatments. In this review, an attempt to make a general assessment of prognostic and predictive methods is made which may be used for planning individualized therapy and also the comments of the guidelines used by the oncologists worldwide on these methods. © 2018, Indian Council of Medical Research. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/14682Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.4103/ijmr.ijmr_1354_17Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorEsbah, Onur
dc.contributor.authorOksuzoglu, Berna
dc.date.accessioned2026-10-18T20:29:28.709355276Z
dc.date.available2026-10-18T20:29:28.709355276Z
dc.date.issued2017
dc.description.abstractBreast cancer is a heterogeneous disease and may present with different clinical and biological characteristics. At present, breast cancer is divided into molecular subgroups besides its histopathological classification. Decision for adjuvant chemotherapy is made based on not only histopathological characteristics but also molecular and genomic characteristics using indices, guidelines and calculators in early-stage breast cancer. Making a treatment plan through all these prognostic and predictive methods according to risk categories aims at preventing unnecessary or useless treatments. In this review, an attempt to make a general assessment of prognostic and predictive methods is made which may be used for planning individualized therapy and also the comments of the guidelines used by the oncologists worldwide on these methods. © 2018, Indian Council of Medical Research. All rights reserved.
dc.identifier.doi10.4103/ijmr.ijmr_1354_17
dc.identifier.endpage571
dc.identifier.issn0971-5916
dc.identifier.issueNovmeber
dc.identifier.pmcidPMC5861467
dc.identifier.pmid29512598
dc.identifier.scopus2-s2.0-85043988682
dc.identifier.startpage563
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/14682
dc.identifier.volume146
dc.identifier.wosWOS:000426920200004
dc.language.isoen
dc.publisherIndian Council of Medical Research
dc.relation.ispartofIndian Journal of Medical Research
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAdjuvant chemotherapy
dc.subjectEarly-stage breast cancer
dc.subjectPredictive
dc.subjectPrognostic
dc.subjectBreast Neoplasms
dc.subjectChemotherapy, Adjuvant
dc.subjectEstrogen Receptor alpha
dc.subjectFemale
dc.subjectGene Expression Regulation, Neoplastic
dc.subjectHumans
dc.subjectKi-67 Antigen
dc.subjectNeoplasm Staging
dc.subjectPrecision Medicine
dc.subjectPrognosis
dc.subjectReceptor, ErbB-2
dc.subjectanastrozole
dc.subjectaromatase inhibitor
dc.subjectepidermal growth factor receptor 2
dc.subjectKi 67 antigen
dc.subjecttamoxifen
dc.subjecttrastuzumab
dc.subjecttumor marker
dc.subjecturokinase receptor
dc.subjectERBB2 protein, human
dc.subjectestrogen receptor alpha, human
dc.subjectArticle
dc.subjectbreast cancer
dc.subjectcancer hormone therapy
dc.subjectcancer prognosis
dc.subjectcirculating tumor cell
dc.titlePrognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus12
rdl.citation.wos9
rdl.departmentDepartment of Medical Oncology, School of Medicine, Erzincan University, Duzce, Turkey.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)